Abstract
Population genetic screening programs for carrier detection of severe genetic disorders exist worldwide, mainly for beta-thalassemia. These screening programs are either mandatory or voluntary. In several Arab countries and Iran, the state has made thalassemia carrier detection mandatory, while tests for detecting carriers are required by the religious authorities in Cyprus. In all the existing mandatory genetic screening programs, the couples have to get the information about the tests before marriage, but the decision whether or not to marry is left to them. Voluntary programs exist for instance in several Mediterranean countries for the prevention of thalassemia and for several genetic diseases among Jews. While voluntary programs leave the decision to be screened or not to the individual, a major problem is that in many cases awareness about the existence of screening tests is very sparse. Some programs, for instance in Canada or Australia, therefore provide education about genetic tests and screening at school in order to allow the individuals to be able to make an informed decision about their reproductive choices.
Similar content being viewed by others
References
Alhamdan NA, Almazrou YY, Alswaidi FM, Choudhry AJ (2007) Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med 9:372–377
Angastiniotis MA, Hadjiminas MG (1981) Prevention of thalassaemia in Cyprus. Lancet 1:369–371
ASHG/ACMG REPORT Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents. (1995) Am. J. Hum. Genet 57:1233–1241
Barlow-Stewart K, Burnett L, Proos A, Howell V, Huq F, Lazarus R, Aizenberg H (2003) A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students. J Med Genet 40:e45
Beutler E (2006) Lysosomal storage diseases: natural history and ethical and economic aspects. Mol Genet Metab 88:208–215 Epub 2006 Mar 3
Broide E, Zeigler M, Eckstein J, Bach G (1993) Screening for carriers of Tay-Sachs disease in the ultra orthodox Ashkenazi Jewish community in Israel. Am J Med Genet 47:213–215
Cao A, Rosatelli C, Galanello R, Monni G, Olla G, Cossu P, Ristaldi MS (1989) The prevention of thalassemia in Sardinia. Clin Genet 36:277–285
Cao A, Rosatelli MC, Monni G, Galanello R (2002) Screening for thalassemia: a model of success. Obstet Gynecol Clin North Am 29:305–328
Cao A, Congiu R, Sollaino MC, Desogus MF, Demartis FR, Loi D, Cau M, Galanello R (2008) Thalassaemia and glucose-6-phosphate dehydrogenase screening in 13- to 14-year-old students of the Sardinian population: preliminary findings. Community Genet 11:121–128 Epub 2008 Mar 26
Chaabouni-Bouhamed H (2008) Tunisia: communities and community genetics. Community Genet 11:313–323 Epub 2008 Aug 5
Chemke J, Zlotogora J (1997) Genetic services in Israel. Eur J Hum Genet 5(Suppl 2):105–111
Czeizel AE, Gasztonyi Z, Kuliev A (2005) Periconceptional clinics: a medical health care infrastructure of new genetics. Fetal Diagn Ther 20:515–518
Department of Community Genetics (2009) http://www.health.gov.il/genetics
Ebrahim SH, Lo SS, Zhuo J, Han JY, Delvoye P, Zhu L (2006) Models of preconception care implementation in selected countries. Matern Child Health J 105:S37–S42 Epub 2006 Jun 9
Ekstein J, Katzenstein H (2001) The Dor Yeshorim story: community-based carrier screening for Tay-Sachs disease. Adv Genet 44:297–310
Fisher N, Baram M (2005) Tay Sachs screening in Israel–is the consumer aware of the significance of the test results? Nurses Israel (in Hebrew) 172:40–44
Frumkin A, Zlotogora J (2008) Genetic screening for reproductive purposes at school: is it a good strategy? Am J Med Genet A 146:264–269
Gason AA, Sheffield E, Bankier A, Aitken MA, Metcalfe S, Barlow Stewart K, Delatycki MB (2003) Evaluation of a Tay-Sachs disease screening program. Clin Genet 63:386–392
Gason AA, Metcalfe SA, Delatycki MB, Petrou V, Sheffield E, Bankier A, Aitken M (2005) Tay Sachs disease carrier screening in schools: educational alternatives and cheekbrush sampling. Genet Med 7:626–632
Godard B, ten Kate L, Evers-Kiebooms G, Aymé S (2003) Population genetic screening programmes: principles, techniques, practices, and policies. Eur J Hum Genet 11(Suppl 2):S49–S87
Henneman L, Bramsen I, van der Ploeg HM, Adèr HJ, van der Horst HE, Gille JJ, ten Kate LP (2001) Participation in preconceptional carrier couple screening: characteristics, attitudes, and knowledge of both partners. J Med Genet 38:695–703
Hesketh T (2003) Getting married in China: pass the medical first. BMJ 326:277–279
Holtzman NA (1998) Eugenics and genetic testing. Sci Context 11:397–417
Kaback MM (2001) Screening and prevention in Tay-Sachs disease: origins, update, and impact. Adv Genet 44:253–265
Kalokairinou EM (2007) The experience of beta-thalassaemia and its prevention in Cyprus. Med Law 26:291–307
Koren A, Zalman L, Palmor H, Ekstein E, Schneour Y, Schneour A, Shalev S, Rachmilewitz EA, Filon D, Openhaim A (2002) The prevention programs for beta thalassemia in the Jezreel and Eiron valleys: results of fifteen years experience. Harefuah 141:938–943
Mao X (1998) Chinese geneticists’ views of ethical issues in genetic testing and screening: evidence for eugenics in China. Am J Hum Genet 63:688–695
Markel H (1992) The stigma of disease: implications of genetic screening. Am J Med 93:209–215
Mitchell JJ, Capua A, Clow C, Scriver CR (1996) Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools. Am J Hum Genet 59:793–798
Rashed Khater RT, El Gazali S (2003) Premarriage checkup in Egypt. rapid response to: Hesketh T getting married in China: pass the medical first. BMJ 326:277–279
Raz AE, Vizner Y (2008) Carrier matching and collective socialization in community genetics: Dor Yeshorim and the reinforcement of stigma. Soc Sci Med 67:1361–1369 Epub 2008 Aug 11
Samavat A, Modell B (2004) Iranian national thalassaemia screening programme. BMJ 329:1134–1137
Schwartz CR (2008) Heredity and hope: the case for genetic screening. Harvard University Press, Cambridge
Zeesman S, Clow CK, Cartier L, Scriver CR (1994) A private view of heterozygosity: eight year follow-up on carriers of Tay-Sachs gene detected by high school screening. Am J Med Genet 18:769–778
Zlotogora J, Israeli A (2009) A comprehensive screening program for cystic fibrosis. IMAJ (in press)
Zlotogora J, Leventhal A (2000) Screening for genetic disorders among Jews: how should the Tay Sachs screening program be continued? IMAJ 2:665–667
Zlotogora J, Carmi R, Lev B, Shalev SA (2008) A targeted population carrier screening program for severe and frequent genetic diseases in Israel. Eur J Hum Genet December 24. [Epub ahead of print]
Zuckerman S, Lahad A, Shmueli A, Zimran A, Peleg L, Orr-Urtreger A, Levy-Lahad E, Sagi M (2007) Carrier screening for Gaucher disease: lessons for low-penetrance, treatable diseases. JAMA 298:1281–1290
Author information
Authors and Affiliations
Corresponding author
Additional information
This article represents the opinions of the author and not necessarily those of the Ministry.
Rights and permissions
About this article
Cite this article
Zlotogora, J. Population programs for the detection of couples at risk for severe monogenic genetic diseases. Hum Genet 126, 247–253 (2009). https://doi.org/10.1007/s00439-009-0669-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-009-0669-y